A Safety and Efficacy Study of Xolair in Peanut Allergy

Summary

This is a 38-week, randomized, double-blind, placebo-controlled, parallel group trial of approximately 150 patients who have a history of immediate hypersensitivity reaction to peanut protein.

Timeline

Start

2004-06

Primary completion

—

Completion

2006-04

Drugs

Indications